These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Critical evaluation of indications for lipid reduction. Cholesterol value updated--risk counts (interview by Dr. Kirsten Westphal)]. Motz W MMW Fortschr Med; 2003 Oct; 145(41):48. PubMed ID: 14655487 [No Abstract] [Full Text] [Related]
7. [Evaluation of the efficacy of statin therapy in dyslipidemic diseases such as combined hypercholesterolemia IIA and hyperlipidemia]. Liguori E; Sarcinella R Minerva Cardioangiol; 1998 Sep; 46(9):317-8. PubMed ID: 10021861 [No Abstract] [Full Text] [Related]
8. [Hemorheological aspects of hyperlipidemia]. Elishkewitch K; Shapira I; Berliner S Harefuah; 2001 May; 140(5):435-6. PubMed ID: 11419070 [No Abstract] [Full Text] [Related]
9. Changing face of dyslipidemia therapy. Banerjee AK Indian Heart J; 2008; 60(3):192-4. PubMed ID: 19240305 [No Abstract] [Full Text] [Related]
10. Alternate-day statin therapy for the treatment of hyperlipidemia. Reindl EK; Wright BM; Wargo KA Ann Pharmacother; 2010 Sep; 44(9):1459-70. PubMed ID: 20702760 [TBL] [Abstract][Full Text] [Related]
11. Lipid control may require more than a statin. Additional medications or lifestyle changes may be necessary to lower total bad cholesterol and raise good cholesterol. Heart Advis; 2008 Nov; 11(11):6. PubMed ID: 19177684 [No Abstract] [Full Text] [Related]
12. Should we change our lipid management strategies to focus on non-high-density lipoprotein cholesterol? Rana JS; Boekholdt SM Curr Opin Cardiol; 2010 Nov; 25(6):622-6. PubMed ID: 20852414 [TBL] [Abstract][Full Text] [Related]
13. Ezetimibe: a turbocharger for the race to reach NCEP LDL goals. Lee S S D J Med; 2005 Oct; 58(10):435-6. PubMed ID: 16425945 [No Abstract] [Full Text] [Related]
14. Atorvastatin: a new agent for hyperlipidemia. Kupecz D Nurse Pract; 1997 Nov; 22(11):87-8, 90, 93. PubMed ID: 9403876 [No Abstract] [Full Text] [Related]
15. Statins and stroke prevention: focus on women. Bushnell CD Ital Heart J; 2004 Aug; 5(8):569-71. PubMed ID: 15554026 [No Abstract] [Full Text] [Related]
16. Development of chromatographic method for determination of drugs reducing cholesterol level. Kublin E; Malanowicz E; Kaczmarska-Graczyk B; Mazurek AP Acta Pol Pharm; 2012; 69(1):139-43. PubMed ID: 22574518 [No Abstract] [Full Text] [Related]
17. [Hypercholesterolemia - the way to lower LDL-C < 55 mg/dl]. Vogt A MMW Fortschr Med; 2020 Nov; 162(Suppl 3):36-42. PubMed ID: 33164189 [No Abstract] [Full Text] [Related]